Literature DB >> 12574350

Role of double-negative regulatory T cells in long-term cardiac xenograft survival.

Wenhao Chen1, Megan S Ford, Kevin J Young, Myron I Cybulsky, Li Zhang.   

Abstract

A novel subset of CD3(+)CD4(-)CD8(-) (double negative; DN) regulatory T cells has recently been shown to induce donor-specific skin allograft acceptance following donor lymphocyte infusion (DLI). In this study, we investigated the effect of DLI on rat to mouse cardiac xenotransplant survival and the ability of DN T cells to regulate xenoreactive T cells. B6 mice were given either DLI from Lewis rats, a short course of depleting anti-CD4 mAb, both DLI and anti-CD4 treatment together, or left untreated. DLI alone did not prolong graft survival when compared with untreated controls. Although anti-CD4-depleting mAb alone significantly prolonged graft survival, grafts were eventually rejected by all recipients. However, the combination of DLI and anti-CD4 treatment induced permanent cardiac xenograft survival. We demonstrate that recipients given both DLI and anti-CD4 treatment had a significant increase in the total number of DN T cells in their spleens when compared with all other treatment groups. Furthermore, DN T cells harvested from the spleens of DLI plus anti-CD4-treated mice could dose-dependently inhibit the proliferation of syngeneic antidonor T cells. Suppression mediated by these DN T cells was specific for antidonor T cells as T cells stimulated by third-party Ags were not suppressed. These results demonstrate for the first time that a combination of pretransplant DLI and anti-CD4-depleting mAb can induce permanent survival of rat to mouse cardiac xenografts and that DN T regulatory cells play an important role in preventing long-term concordant xenograft rejection through the specific suppression of antidonor T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574350     DOI: 10.4049/jimmunol.170.4.1846

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

Review 2.  Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

Authors:  Stephen C Juvet; Li Zhang
Journal:  J Mol Cell Biol       Date:  2012-02       Impact factor: 6.216

Review 3.  Double-negative regulatory T cells: non-conventional regulators.

Authors:  Christopher W Thomson; Boris P-L Lee; Li Zhang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Infusion of ex-vivo expanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease.

Authors:  P Achita; D Dervovic; D Ly; J B Lee; T Haug; B Joe; N Hirano; L Zhang
Journal:  Clin Exp Immunol       Date:  2018-07-31       Impact factor: 4.330

Review 5.  Making sense of regulatory T cell suppressive function.

Authors:  Itay Shalev; Moritz Schmelzle; Simon C Robson; Gary Levy
Journal:  Semin Immunol       Date:  2011-05-17       Impact factor: 11.130

Review 6.  Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation.

Authors:  Ann J Ligocki; Jerry Y Niederkorn
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

7.  Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Authors:  Beverly Duncan; Cristina Nazarov-Stoica; Jacqueline Surls; Margaret Kehl; Constantin Bona; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

Review 8.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

9.  Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.

Authors:  Stephen C Juvet; Mei Han; Ramesh Vanama; Betty Joe; Edward Y Kim; Fei Linda Zhao; Caroline Jeon; Oyedele Adeyi; Li Zhang
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.

Authors:  Erin E Hillhouse; Jean-Sébastien Delisle; Sylvie Lesage
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.